NCT07125053 COPD Resources, Education, and Activity Designed for You Study
| NCT ID | NCT07125053 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Rush University Medical Center |
| Condition | COPD |
| Study Type | INTERVENTIONAL |
| Enrollment | 448 participants |
| Start Date | 2025-08-18 |
| Primary Completion | 2029-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 448 participants in total. It began in 2025-08-18 with a primary completion date of 2029-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Although COPD self-management treatment programs are effective in reducing COPD-related hospitalizations and increasing quality of life, there is a limited understanding of 'how and why' they work. The proposed research will use an engineering-inspired study design to identify effective COPD self-management treatment components and guide its 'real world' implementation. The long-term goal of this line of research is to build an optimized COPD self-management program, and scale the program up to reduce the burden of COPD at a population health level.
Eligibility Criteria
Inclusion Criteria: * Residence in the continental United States * Age 40 years or older * Report a physician diagnosis of COPD * Report a COPD-related hospitalization over the past 12 months * Use an inhaled medication for COPD at least once per week * Have access to a connected device (i.e., smartphone, tablet, and/ or computer) to complete study procedures Exclusion Criteria: * COPD exacerbation within the past month * New or worsening chest pain that happens without exertion * Cognitive dysfunction impairing ability to provide informed consent and follow study procedures * Terminal illness (i.e., \< 6 month life expectancy) that is non-COPD related * Living at a chronic care facility (i.e., nursing home, assisted living) * Inability to participate in mild physical activity such as walking, stretching, and lower limb exercises * Inability to speak/ read English
Contact & Investigator
Amanda R. Mathew, PhD
PRINCIPAL INVESTIGATOR
Rush University Medical Center
Frequently Asked Questions
Who can join the NCT07125053 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, studying COPD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07125053 currently recruiting?
Yes, NCT07125053 is actively recruiting participants. Contact the research team at COPD_READY@rush.edu for enrollment information.
Where is the NCT07125053 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT07125053 clinical trial?
NCT07125053 is sponsored by Rush University Medical Center. The principal investigator is Amanda R. Mathew, PhD at Rush University Medical Center. The trial plans to enroll 448 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.